EVALUACION IN VITRO de una nueva técnica para la toma de impresiones • definitivas en prótesis fija

La toma de impresiones definitivas en prótesis fija, es uno de los procedimientos rutinarios en la práctica odontológica que requiere mayor destreza y habilidad por parte del odontólogo; los requisitos como fidelidad, precisión y exactitud de las impresiones definitivas en dientes preparados con márgenes supragingivales o intracreviculares, son esenciales y se deben lograr por medio de técnicas que no sean incómodas para el paciente, que no lastimen los tejidos periodontales y que ahorren tiempo y dinero

Volcanic sequence in Late Triassic – Jurassicsiliciclastic and evaporitic rocks from Galeana, NE Mexico

In northeastern Mexico, volcanic rocks interbedded with Late Triassic–Jurassic siliciclastic and evaporitic strata have been linked to magmatic arcs developed in the Pangea western margin during its initial phase of fragmentation. This work provides new petrographic and geochemical data for volcanism included in the El Alamar and Minas Viejas formations outcropping in the Galeana region. Andesitic dykes and sills (n= 10) in the El Alamar redbeds show SiO2= 47.5–59.1% and MgO= 1.2–4.2%, as well as a geochemical affinity to island arc magmas. This work represents the first report of this tectonic setting in the region. Geological and petrographic evidence suggest that this arc system likely developed after ~220 and before ~193Ma. Trachy-andesitic and rhyodacitic domes (n= 20) associated with the Minas Viejas gypsum-carbonates sequence show SiO2= 61.8–82.7% and MgO= 0.1–4.0% with a tectonic affinity to continental arc. A rhyodacite sample from this region has been dated by U-Pb in zircon, yielding an age of 149.4 ± 1.2Ma (n= 21), being the youngest age related to this arc. Finally, we propose a threestep model to explain the tectonic evolution from Late Triassic island arc to Jurassic continental arc system in the northeastern Mexico

SVET study of the interaction of 2-Mercaptobenzothiazole corrosion inhibitor with Au, Cu and Au-Cu galvanic coupling

This study reports an electrochemical investigation of the interaction between 2-mercaptobenzothiazole (2MBT), a corrosion inhibitor, and two noble metals (Cu and Au), either isolated or under galvanical coupling. The surface reactivity of the inhibitor-modified metals in chloride-containing aqueous solution of 0.1 mM NaCl was studied using the Scanning Vibrating Electrode Technique (SVET). The potential gradients in the electrolyte were detected by the SVET and converted to local ionic currents distributed at different anodic and cathodic sites, where electrochemical redox reactions are taking place. No external polarization was applied during SVET measurements, leaving the samples at the spontaneous free corrosion potential (FCP). The values of FCP showed that the metals are not protected by 2MBT. SVET revealed a moderate electrochemical activity of Au and very low in the case of Cu

Investigating metal-inhibitor interaction with EQCM and SVET: 3-amino-1,2,4-triazole on Au, Cu and Au-Cu galvanic coupling

In this work, the scanning vibrating electrode technique (SVET) and the quartz crystal microbalance technique (EQCM) were used to characterize the electrochemical interaction of two corrosion inhibitors, 2-Mercaptobenzothiazole and 3-Amino-1,2,4-triazole (ATA), in Au and Cu samples individually and with both metals connected in order to form a galvanic pair Au-C

Intracellular calcium movements of boar spermatozoa during 'in vitro' capacitation and subsequent acrosome exocytosis follow a multiple-storage place, extracellular calcium-dependent model

This work analysed intracellular calcium stores of boar spermatozoa subjected to invitro' capacitation (IVC) and subsequent progesterone-induced acrosome exocytosis (IVAE). Intracellular calcium was analysed through two calcium markers with different physico-chemical properties, Fluo-3 and Rhod-5N. Indicative parameters of IVC and IVAE were also evaluated. Fluo-3 was located at both the midpiece and the whole head. Rhod-5N was present at the sperm head. This distribution did not change in any of the assayed conditions. Induction of IVC was concomitant with an increase in both head and midpiece Ca2+ signals. Additionally, while IVC induction was concurrent with a significant (p<0.05) increase in sperm membrane permeability, no significant changes were observed in O-2 consumption and ATP levels. Incubation of boar spermatozoa in the absence of calcium showed a loss of both Ca2+ labellings concomitantly with the sperm's inability to achieve IVC. The absence of extracellular calcium also induced a severe decrease in the percentage of spermatozoa exhibiting high mitochondrial membrane potential (hMMP). The IVAE was accompanied by a fast increase in both Ca2+ signalling in control spermatozoa. These peaks were either not detected or much lessened in the absence of calcium. Remarkably, Fluo-3 marking at the midpiece increased after progesterone addition to sperm cells incubated in a medium without Ca2+. The simultaneous addition of progesterone with the calcium chelant EGTA inhibited IVAE, and this was accompanied by a significant (p<0.05) decrease in the intensity of progesterone Ca2+-induced peak, O-2 consumption and ATP levels. Our results suggest that boar spermatozoa present different calcium deposits with a dynamic equilibrium among them and with the extracellular environment. Additionally, the modulation role of the intracellular calcium in spermatozoa function seems to rely on its precise localization in boar spermatozoa

'In vitro' capacitation and acrosome reaction are concomitant with specific changes in mitochondrial activity in boar sperm: evidence for a nucleated mitochondrial activation and for the existence of a capacitation-sensitive subpopulational structure

The main scope of this manuscript is to analyse the dynamics of mitochondrial activity in boar sperm subjected to 'in vitro' capacitation (IVC) and subsequent progesterone-induced 'in vitro' acrosome reaction (IVAR). This was determined after analysis of the rhythm of O(2) consumption and concomitant changes in the mitochondria activity-specific JC-1 staining. Results showed that IVC, and especially IVAR, was concomitant with a peak in O(2) consumption (from 1.61 ± 0.08 nmol O(2)/min/10(7) viable sperm at 0 h of incubation to 2.62 ± 0.12 nmol O(2) /min/10(7) viable sperm after 5 min of IVAR induction). These results were accompanied by parallel changes in the mean intensity of JC-1 staining. Based on JC-1, mitochondrial activation followed a nucleated pattern, with specific, activation starting points at the midpiece from which mitochondrial activation was spread. Moreover, four separate sperm subpopulations were detected following the JC-1 orange-red/green ratio, and the observed changes in the mean JC-1 staining during IVC and IVAR were related to concomitant changes in both the orange-red/green JC-1 ratio and the percentage of sperm included in each subpopulation. All of these results indicate that IVC and the first minutes of IVAR are accompanied by a progressive increase in mitochondrial activity, which reached a peak coincidental with the achievement of IVAR. Moreover, results suggest the presence of separate sperm subpopulations, which show a different mitochondrial sensitivity to IVC and IVAR. Finally, mitochondrial activation, at least under JC-1 staining, seems to originate in concrete nucleation points at the midpiece, thus suggesting thus a well-coordinated pattern in boar-sperm mitochondrial activity modulation

High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance

It has been postulated that monitoring measurable residual disease (MRD) could be used as a surrogate marker of progression-free survival (PFS) in chronic lymphocytic leukemia (CLL) patients after treatment with immunochemotherapy regimens. In this study, we analyzed the outcome of 84 patients at 3 years of follow-up after first-line treatment with fludarabine, cyclophosphamide and rituximab (FCR) induction followed by 36 months of rituximab maintenance thearpy. MRD was assessed by a quantitative four-color flow cytometry panel with a sensitivity level of 10-4. Eighty out of 84 evaluable patients (95.2%) achieved at least a partial response or better at the end of induction. After clinical evaluation, 74 patients went into rituximab maintenance and the primary endpoint was assessed in the final analysis at 3 years of follow-up. Bone marrow (BM) MRD analysis was performed after the last planned induction course and every 6 months in cases with detectable residual disease during the 36 months of maintenance therapy. Thirty-seven patients (44%) did not have detectable residual disease in the BM prior to maintenance therapy. Interestingly, 29 patients with detectable residual disease in the BM after induction no longer had detectable disease in the BM following maintenance therapy. After a median followup of 6.30 years, the median overall survival (OS) and PFS had not been reached in patients with either undetectable or detectable residual disease in the BM, who had achieved a complete response at the time of starting maintenance therapy. Interestingly, univariate analysis showed that after rituximab maintenance OS was not affected by IGHV status (mutated vs. unmutated OS: 85.7% alive at 7.2 years vs. 79.6% alive at 7.3 years, respectively). As per protocol, 15 patients (17.8%), who achieved a complete response and undetectable peripheral blood and BM residual disease after four courses of induction, were allowed to stop fludarabine and cyclophosphamide and complete two additional courses of rituximab and continue with maintenance therapy for 18 cycles. Surprisingly, the outcome in this population was similar to that observed in patients who received the full six cycles of the induction regimen. These data show that, compared to historic controls, patients treated with FCR followed by rituximab maintenance have high-quality responses with fewer relapses and improved OS. The tolerability of this regime is favorable. Furthermore, attaining an early undetectable residual disease status could shorten the duration of chemoimmunotherapy, reducing toxicities and preventing long-term side effects. The analysis of BM MRD after fludarabine-based induction could be a powerful predictor of post-maintenance outcomes in patients with CLL undergoing rituximab maintenance and could be a valuable tool to identify patients at high risk of relapse, influencing further treatment strategies

Sensitization Toward Organ Donation Among Medical Students in Spanish Regions With More Than 50 Donors Per Million Population

The awareness of organ donation among health professionals is important at the time of transplant promotion. In this sense, the training and awareness of the professionals in training is fundamental